MV
Therapeutic Areas
Mariana Oncology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DLL3-Targeted RLT | DLL3-expressing cancers (e.g., small cell lung cancer, neuroendocrine cancers) | Preclinical |
| B7-H3-Targeted RLT | B7-H3-expressing solid tumors | Preclinical |
Leadership Team at Mariana Oncology
FZ
Fred Zecri, PhD
Chief Scientific Officer – Site Head
TT
Travis Tirrell, MS, JD
Chief Operating Officer and General Counsel
BD
Bill Diamantopoulos, PharmD
Chief Technology Officer
CB
Caroline Breitbach, PhD
SVP, Asset & Portfolio Leadership